Sharechat Logo

Aussies buy Biolab from Tiongs

By Christine Nikiel

Friday 4th April 2003

Text too small?
Australian-listed Alesco Corporation is to buy Biolab, part of Salmond Smith Biolab and owned by one of Malaysia's richest families, for $53 million.

Through New Zealand manager Thomas Song, the Tiong family has been selling down divisions of SSB since its takeover in 1995 after the company had delisted.

Biolab is Australasia's biggest supplier and distributor of scientific instruments and goods but became a victim of the tech wreck.

Its e-commerce arm, an online marketplace called OneZone, collapsed in 2001 because of slow user uptake.

Another factor was its failure to secured any third-party equity.

SSB was a sharemarket favourite in the early 1990's when it bought into salmon farming but sorry performances from its fishing quotas ended in the Tiong takeover and the sale of all fishing assets.

Alesco will add Biolab to its building products, earthmoving tyres and automotive parts divisions.

The Alesco-SSB Overseas Investment Commission decision was the second biggest sale in February.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

May 20th Morning Report
May 19th Morning Report
PYS - PaySauce to announce F26 full year results on 27 May 2026
PEB - Draft LCD Proposes Medicare Coverage for Triage and Triage
MEL - Meridian Energy monthly operating report for April 2026
FBU - Sale of South Australian property
AIR - Air New Zealand market update
May 14th Morning Report
PEB - Pacific Edge Placement Increased to NZ$25.4 Million
Radius Care Reports Earnings Growth and 50% Higher Dividend